Consistent shortage of trained nurses in Punjab hospitals
During the visit, he was briefed on the university's academic, research and public health initiatives.
Brigadier Alauddin (retd) termed the Punjab government's recent decision to centralize admissions to nursing colleges through UHS a 'wise step,' noting that it would promote merit, transparency, and quality education. He disclosed that during his inspections of more than 100 hospitals over the past year, he found a consistent shortage of trained nurses. In that context, he praised UHS's contribution to strengthening standards in nursing education.
Commenting on UHS's adolescent health awareness programme Pyari Beti, he called it a commendable initiative for empowering young girls. 'This programme deserves integration into the primary healthcare system, and I will brief the Chief Minister accordingly,' he added.
He also discussed the Medical and Dental College Admission Test (MDCAT), expressing strong personal support for its continuation as a standardised entry examination. He highlighted the need for an effective and coordinated regulatory framework for monitoring private medical colleges, citing recurring complaints about their academic standards.
The vice-chancellor Prof Rathore informed the delegation that a crackdown on substandard nursing colleges was already underway. 'In future, only those institutions with a minimum 200-bed teaching hospital will be accredited,' he said.
Brigadier Alauddin reiterated that healthcare remains a top priority for the Chief Minister. He noted that Punjab's Basic Health Units (BHUs) and Rural Health Centres (RHCs) were being revitalised and outsourced to the private sector to improve service delivery. Despite serving a significant patient load from across provincial borders, Punjab's public health system continues to deliver, he added.
Praising UHS's distinctive role among national regulators, he said that the university's challenges and its societal impact are unique and vital. He also acknowledged the ongoing efforts to improve the international ranking of Pakistani universities.
Copyright Business Recorder, 2025
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
7 hours ago
- Business Recorder
Highnoon forges alliance with BD's Beximco
KARACHI: Highnoon Laboratories Limited, a prominent Pakistani pharmaceutical company, announces a significant strategic partnership with Beximco Pharmaceuticals Limited, a leading pharmaceutical firm based in Bangladesh. The collaboration aims to enhance the availability of specialised pharmaceutical products in Pakistan, focusing on critical therapeutic areas such as respiratory, diabetes, and cardiovascular diseases. The partnership was formalised through the signing of a Memorandum of Understanding (MoU) between the two companies. This alliance is set to introduce newer therapies, advanced dosage forms, and innovative drug delivery systems to the Pakistani market, promising improved ease of use and better clinical outcomes for patients, while simultaneously enhancing access to advanced medications. Beximco Pharmaceuti-cals Limited brings to the table state-of-the-art manufacturing facilities, which have received accreditation from stringent regulatory authorities across the globe, including the USA, Australia, the European Union, Canada, and Brazil. This robust accreditation underscores Beximco's commitment to quality and international standards. Highnoon Laboratories Limited, recognised as a recipient of Forbes Asia's 'Best Under A Billion' award in 2023, views this strategic alliance as a pivotal step. According to the disclosure made to the Pakistan Stock Exchange Limited, the company believes this partnership will not only benefit patients in Pakistan but also significantly contribute to the ongoing expansion of trade relations and economic cooperation between Pakistan and Bangladesh. The collaboration is expected to bring substantial advancements to Pakistan's healthcare sector, offering new hope and improved treatment options for patients suffering from high-burden diseases. Copyright Business Recorder, 2025
Business Recorder
21 hours ago
- Business Recorder
Highnoon Labs partners with Bangladesh's Beximco to target high-burden diseases in Pakistan
Highnoon Laboratories Limited (HINOON), a Pakistani pharmaceutical company, has announced a strategic partnership with Beximco Pharmaceuticals Limited, a leading Bangladesh-based drug manufacturer, to collaborate on the distribution and marketing of specialised pharmaceutical products in Pakistan. The listed pharmaceutical disclosed the development in its notice to the Pakistan Stock Exchange (PSX) on Tuesday. 'The company has entered into a strategic partnership with Beximco Pharmaceuticals Limited, a leading Bangladesh-based pharmaceutical company having state-of-the-art manufacturing facilities, accredited by the regulatory authorities of the USA, Australia, the European Union, Canada, and Brazil,' read the notice. HINOON shared that a memorandum of understanding (MoU) has been inked between the two companies to collaborate for the distribution and marketing of specialised pharmaceutical products in Pakistan, with the focus on high-burden therapeutic areas including respiratory, diabetes, and cardiovascular diseases. Bangladesh firm opens outlet in Karachi 'Through this partnership, the company will bring newer therapies, dosage forms and delivery systems for the ease of use and better clinical results for patients and improve access to the advanced medications. This strategic alliance will make a significant contribution to the recent expansion of trade relations and economic cooperation between Pakistan and Bangladesh,' read the notice. Beximco Pharmaceuticals Ltd. is an emerging generic drug player committed to providing access to affordable medicines. It currently focuses on building presence in many emerging and developed markets around the world. Meanwhile, Highnoon Laboratories Limited was incorporated in Pakistan as a private limited company in 1984 and was converted into a public limited company in 1995. The principal activity of the company is the manufacturing, import, sale and marketing of pharmaceutical and allied consumer products.
Express Tribune
a day ago
- Express Tribune
President, PM call for joint efforts to combat hepatitis
President Asif Zardari and Prime Minister Shehbaz Sharif have called for concerted efforts to contain the hepatitis epidemic and urged all stakeholders to join hands in a unified response to this growing threat to public health. In their separate messages on 'World Hepatitis Day' being observed on Monday, they said that Pakistan joined the international community in reaffirming the commitment to eliminate hepatitis and protect the health of the people. 'World Hepatitis Day' is observed to raise awareness about the dangers of disease and to promote collective action to prevent and control it. They noted that Pakistani healthcare professionals, researchers, and frontline workers were working tirelessly, and they need the community support. "We must implement comprehensive strategies that combine mass awareness campaigns, effective vaccination drives, timely screening and access to treatment. It is imperative to extend these services to all segments of society, especially in underserved and rural areas," Zardari said in his message. In his message, Shehbaz mentioned the launch of the Prime Minister's National Programme for the Elimination of Hepatitis C, which aimed to screen over 165 million people by 2030 and provide free treatment to all positive cases. "This is a national movement that is a testament to our collective commitment to saving lives and securing the future. To make this vision a reality, we call on different segments of society to contribute to the efforts to end this scourge," he said. He said raising awareness about hepatitis is essential to break the stigma surrounding the disease.
